|
楼主 |
发表于 12-5-2020 07:36 AM
|
显示全部楼层
Notice of Person Ceasing (Section 139 of CA 2016)MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD | Particulars of Substantial Securities HolderName | TAN SRI DATO' SRI KOH KIN LIP, JP | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Date of cessation | 16 Mar 2020 | Name & address of registered holder | Alliancegroup Nominees (Tempatan) Sdn Bhd Pledged Securities Account for Koh Kin Lip (7003423)17th Floor, Menara Multi-Purpose Capital Square No. 8, Jln Munshi Abdullah, 50100 Kuala Lumpur |
No of securities disposed | 233,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal of ordinary shares in open market | Nature of interest | Direct Interest | | Date of notice | 17 Mar 2020 | Date notice received by Listed Issuer | 17 Mar 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 31-5-2020 08:17 AM
|
显示全部楼层
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Particulars of substantial Securities HolderName | SYNAMATIX SDN. BHD. | Address | No. 27-9, Level 9 Signature Office,
Bandar Mid Valley,
Kuala Lumpur
59200 Wilayah Persekutuan
Malaysia. | Company No. | 200101002725 (538481-U) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 27 Apr 2020 | 10,000,000 | Disposed | Direct Interest | Name of registered holder | Synamatix Sdn. Bhd. | Address of registered holder | No. 27-9, Level 9 Signature Office, Bandar Mid Valley, 59200 Kuala Lumpur, Wilayah Persekutuan | Description of "Others" Type of Transaction | | 2 | 27 Apr 2020 | 7,000,000 | Disposed | Direct Interest | Name of registered holder | Synamatix Sdn. Bhd. | Address of registered holder | No. 27-9, Level 9 Signature Office, Bandar Mid Valley, 59200 Kuala Lumpur, Wilayah Persekutuan | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of shares in open market. | Nature of interest | Direct Interest | Direct (units) | 12,354,070 | Direct (%) | 11.935 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 12,354,070 | Date of notice | 27 Apr 2020 | Date notice received by Listed Issuer | 27 Apr 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 1-6-2020 07:20 AM
|
显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD | Particulars of Substantial Securities HolderName | MOHAAMAD SHAMIN BIN MOHAAMAD SAHAFI | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name & address of registered holder | No. 12, Jalan SU 39, Taman Selayang Utama,68100 Batu Caves, Selangor |
Date interest acquired & no of securities acquired | Date interest acquired | 27 Apr 2020 | No of securities | 7,000,000 | Circumstances by reason of which Securities Holder has interest | Acquisition of shares | Nature of interest | Direct Interest | | Total no of securities after change | Direct (units) | 7,000,000 | Direct (%) | 6.763 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Date of notice | 27 Apr 2020 | Date notice received by Listed Issuer | 28 Apr 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 1-6-2020 07:57 AM
|
显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD | Particulars of Substantial Securities HolderName | LIW CHAI YUK | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name & address of registered holder | Liw Chai Yuk17, The Mansions, Cangkat Intisari, Desa Parkcity, 52200 Kuala LumpurWilayah Persekutuan |
Date interest acquired & no of securities acquired | Date interest acquired | 27 Apr 2020 | No of securities | 10,000,000 | Circumstances by reason of which Securities Holder has interest | Acquisition of shares | Nature of interest | Direct Interest | | Total no of securities after change | Direct (units) | 10,000,000 | Direct (%) | 9.661 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Date of notice | 27 Apr 2020 | Date notice received by Listed Issuer | 29 Apr 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 1-6-2020 07:58 AM
|
显示全部楼层
Notice of Person Ceasing (Section 139 of CA 2016)MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD | Particulars of Substantial Securities HolderName | SYNAMATIX SDN. BHD. | Address | No. 27-9, Level 9 Signature Office,
Bandar Mid Valley,
Kuala Lumpur
59200 Wilayah Persekutuan
Malaysia. | Company No. | 200101002725 (538481-U) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Date of cessation | 13 May 2020 | Name & address of registered holder | Synamatix Sdn. Bhd.No. 27-9, Level 9 Signature Office,Bandar Mid Valley,59200 Kuala Lumpur, Wilayah Persekutuan |
No of securities disposed | 12,000,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal of shares in open market. | Nature of interest | Direct Interest | | Date of notice | 13 May 2020 | Date notice received by Listed Issuer | 13 May 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 5-6-2020 08:39 AM
|
显示全部楼层
Notice of Person Ceasing (Section 139 of CA 2016)MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD | Particulars of Substantial Securities HolderName | SYNAMATIX SDN. BHD. | Address | No. 27-9, Level 9 Signature Office,
Bandar Mid Valley,
Kuala Lumpur
59200 Wilayah Persekutuan
Malaysia. | Company No. | 200101002725 (538481-U) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Date of cessation | 13 May 2020 | Name & address of registered holder | Synamatix Sdn. Bhd.No. 27-9, Level 9 Signature Office,Bandar Mid Valley,59200 Kuala Lumpur, Wilayah Persekutuan |
No of securities disposed | 12,000,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal of shares in open market. | Nature of interest | Direct Interest | | Date of notice | 13 May 2020 | Date notice received by Listed Issuer | 13 May 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 6-6-2020 06:49 AM
|
显示全部楼层
Notice of Person Ceasing (Section 139 of CA 2016)MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD | Particulars of Substantial Securities HolderName | MOHAAMAD SHAMIN BIN MOHAAMAD SAHAFI | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Date of cessation | 12 May 2020 | Name & address of registered holder | Mohaamad Shamin Bin Mohaamad SahafiNo. 12, Jalan SU 39,Taman Selayang Utama,68100 Batu Caves, Selangor |
No of securities disposed | 2,181,700 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal of shares | Nature of interest | Direct Interest | | Date of notice | 14 May 2020 | Date notice received by Listed Issuer | 14 May 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 7-6-2020 07:27 AM
|
显示全部楼层
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Particulars of substantial Securities HolderName | LIW CHAI YUK | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 13 May 2020 | 3,139,000 | Disposed | Direct Interest | Name of registered holder | Liw Chai Yuk | Address of registered holder | 17, The Mansions, Cangkat Intisari, Desa Parkcity, 52200 Kuala Lumpur Wilayah Persekutuan | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of shares | Nature of interest | Direct Interest | Direct (units) | 6,861,000 | Direct (%) | 6.628 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 6,861,000 | Date of notice | 15 May 2020 | Date notice received by Listed Issuer | 15 May 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 10-6-2020 08:49 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2020 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Mar 2020 | 31 Mar 2019 | 31 Mar 2020 | 31 Mar 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 308 | 199 | 5,447 | 452 | 2 | Profit/(loss) before tax | -1,663 | -744 | 22,536 | -2,823 | 3 | Profit/(loss) for the period | -1,663 | -958 | 22,536 | -2,495 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -1,663 | -958 | 22,536 | -2,495 | 5 | Basic earnings/(loss) per share (Subunit) | -1.61 | -0.93 | 21.77 | -2.41 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 12.4200 | 15.3900
|
|
|
|
|
|
|
|
|
楼主 |
发表于 11-8-2020 08:24 AM
|
显示全部楼层
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Date of change | 10 Jun 2020 | Name | MISS GRACE HOW PEI YEN | Age | 39 | Gender | Female | Nationality | Malaysia | Designation | Director | Directorate | Executive | Type of change | Appointment | QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | 1 | Professional Qualification | Member of Association of Chartered Certified Accountants | - | | 2 | Professional Qualification | Registered Financial Planner of Malaysian Financial Planning Council | - | | 3 | Professional Qualification | Bachelor of Science in Degree in Applied Accounting | Oxford Brooks University, United Kingdom | | 4 | Others | London Chamber of Commerce Industry | - | |
Working experience and occupation | Ms. Grace How Pei Yen begins her career with PricewaterhouseCoopers Malaysia which focuses on consumer industries. She then involves her skillsets and experience in investments and finance which includes hedge funds, mutual funds, real estate, stocks investment as well as private placement. Her working experience includes portfolio management and business strategies planning. |
|
|
|
|
|
|
|
|
楼主 |
发表于 3-10-2020 05:14 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company")-TRIPARTITE AGREEMENT WITH ICARTAB BIOMEDICAL CO. LTD. ("ICARTAB") AND ADVANCED IMMUNE THERAPEUTICS SDN. BHD. ("AIT") IN RELATION TO ADVANCE THERAPEUTICS PRIMARILY IN T-CELL BASED THERAPY | The Board of Directors of the Company wishes to announce that the Company had on 26 June 2020 entered into a tripartite agreement with ICARTAB and AIT to be granted exclusive rights in respect of the distribution, production and commercialisation of therapeutics for personalised healthcare primarily in Chimeric Antigen Receptor T cells (“CAR-T cells”) for solid cancers (“Tripartite Agreement”).
Please refer to the attachment below for further details of the Tripartite Agreement.
This announcement is dated 26 June 2020. | https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3062569
|
|
|
|
|
|
|
|
楼主 |
发表于 10-10-2020 08:25 AM
|
显示全部楼层
本帖最后由 icy97 于 1-3-2021 08:32 AM 编辑
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Date of change | 30 Jun 2020 | Name | ENCIK ROBERT GEORGE HERCUS @ ABDUL KARIM HERCUS | Age | 72 | Gender | Male | Nationality | Malaysia | Designation | Managing Director | Directorate | Executive | Type of change | Resignation | Reason | Due to Mutual Separation Scheme | Details of any disagreement that he/she has with the Board of Directors | No | Whether there are any matters that need to be brought to the attention of shareholders | No | QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information |
Working experience and occupation | N/A | Family relationship with any director and/or major shareholder of the listed issuer | He is the spouse of Datuk Munirah binti Haji Abdul Hamid, a director of the Company. | Any conflict of interests that he/she has with the listed issuer | Nil | Details of any interest in the securities of the listed issuer or its subsidiaries | Direct Interest:Robert George Hercus @ Abdul Karim Hercus - 80,000 ordinary sharesIndirect interest:Deemed interested through Synamatix Sdn. Bhd. pursuant to Section 8 of the Companies Act 2016 - 354,070 ordinary sharesDeemed interested through Neuramatix Sdn. Bhd. pursuant to Section 8 of the Companies Act 2016 - 50 ordinary sharesDeemed interested through his son, Adlan Hercus pursuant to Section 59 of the Companies Act 2016 - 28,000 ordinary shares |
|
|
|
|
|
|
|
|
楼主 |
发表于 18-12-2020 09:53 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2020 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Jun 2020 | 30 Jun 2019 | 30 Jun 2020 | 30 Jun 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 3 | 140 | 951 | 592 | 2 | Profit/(loss) before tax | -2,610 | -1,259 | 16,869 | -4,082 | 3 | Profit/(loss) for the period | -5,436 | -1,343 | 17,100 | -3,838 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -5,436 | -1,343 | 17,100 | -3,838 | 5 | Basic earnings/(loss) per share (Subunit) | -5.25 | -1.30 | 16.52 | -3.71 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 22.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0991 | 0.1539
|
|
|
|
|
|
|
|
|
楼主 |
发表于 19-12-2020 07:16 AM
|
显示全部楼层
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Date of change | 21 Aug 2020 | Name | DATUK MUNIRAH BINTI HAJI ABDUL HAMID | Age | 70 | Gender | Female | Nationality | Malaysia | Type of change | Redesignation | Previous Position | Executive Director | New Position | Non Executive Director | Directorate | Non Independent and Non Executive |
Date of change | 21 Aug 2020 | Name | DATO ALVIN JOSEPH NESAKUMAR | Age | 52 | Gender | Male | Nationality | Malaysia | Type of change | Redesignation | Previous Position | Non Executive Director | New Position | Executive Director | Directorate | Executive |
|
|
|
|
|
|
|
|
楼主 |
发表于 19-1-2021 07:53 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "COMPANY") Incorporation of new Subsidiaries | The Board of Directors of MGRC wishes to announce that the following subsidiary of the Company have been incorporated on 21 September 2020:- NAME | PAID-UP CAPITAL | SHAREHOLDERS & SHAREHOLDINGS | DIRECTORS | MGRC Therapeutics Sdn. Bhd. [Registration No.: 202001028925 (1385245-P)] | RM2.00 comprising 2 ordinary shares
| Malaysian Genomics Resource Centre Berhad (100%)
| - Dato’ Alvin Joseph Nesakumar
- Grace How Pei Yen
|
(hereinafter referred as “the Incorporation of Subsidiary”)
The principal activity(ies) of the abovementioned subsidiary of the Company is as follows:- NAME | PRINCIPAL ACTIVITY | MGRC Therapeutics Sdn. Bhd. [Registration No.: 202001028925 (1385245-P)] | Provision of services relating to Life Sciences/Cell Laboratory and by Products |
The Incorporation of the Subsidiary is expected to contribute positively to the earnings per share and net assets of the Company for the financial year ending 30 June 2021. However, the Incorporation of Subsidiary will not have any material effect on the gearing, share capital for the financial year ending 30 June 2021 and substantial shareholders’ shareholdings of the Company. None of the Directors or Major Shareholders or persons connected to the Directors or Major Shareholders has any interest, direct or indirect, in the aforesaid incorporation.
The Board of Directors of the Company, after having taken into consideration the Incorporation of Subsidiary, is of opinion that the Incorporation of Subsidiary is in the best interest of MGRC.
The Incorporation of Subsidiary does not require the approval of shareholders of the Company.
This announcement is dated 22 September 2020. |
|
|
|
|
|
|
|
|
楼主 |
发表于 21-1-2021 07:20 AM
|
显示全部楼层
本帖最后由 icy97 于 18-2-2021 09:15 AM 编辑
Change in Principal OfficerMALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Date of change | 23 Sep 2020 | Name | ENCIK SASHA OMAR FIRDAUS BIN AAMIR NORDIN | Age | 46 | Gender | Male | Nationality | Malaysia | Type of change | Appointment | Designation | Chief Executive Officer | QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | 1 | Masters | Business Administration | University of Strathclyde, Glasgow | | 2 | Degree | Management Studies | University of Waikato, Hamilton | |
| | Working experience and occupation | Encik Sasha was appointed as the Chief Operating Officer of the Company on 1 February 2014. Prior to that he was employed at Neuramatix Sdn Bhd, which was the ultimate holding company of MGRC, for a period of 12 years.Encik Sasha has over 21 years experience in business development, funding raising, project planning and management, product development, and strategic marketing in the areas of genomics, biotechnology, artificial intelligence, and big data mining. | Directorships in public companies and listed issuers (if any) | NIL | Family relationship with any director and/or major shareholder of the listed issuer | NIL | Any conflict of interests that he/she has with the listed issuer | NIL | Details of any interest in the securities of the listed issuer or its subsidiaries | Encik Sasha is holding 86,100 shares in the Company. |
|
|
|
|
|
|
|
|
楼主 |
发表于 25-2-2021 08:21 AM
|
显示全部楼层
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Particulars of substantial Securities HolderName | CREST ADVISORY BERHAD | Address | 100.3.041 129 Offices, Block J,
Jaya One, 72A, Jalan Universiti,
Section 13,
Petaling Jaya
46200 Selangor
Malaysia. | Company No. | 201901013684 (1323012-X) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 05 Oct 2020 | 3,140,000 | Disposed | Direct Interest | Name of registered holder | Crest Advisory Berhad | Address of registered holder | 100.3.041 129 Offices, Block J, Jaya One, 72A, Jalan Universiti, Section 13, 46200 Petaling Jaya, Selangor. | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of 3,140,000 shares in the open market. | Nature of interest | Direct Interest | Direct (units) | 25,860,000 | Direct (%) | 24.983 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 25,860,000 | Date of notice | 05 Oct 2020 | Date notice received by Listed Issuer | 07 Oct 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 1-3-2021 09:04 AM
|
显示全部楼层
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" OR THE "COMPANY")PROPOSED DIVERSIFICATION OF THE BUSINESSES OF MGRC AND ITS SUBSIDIARIES TO INCLUDE BIOPHARMACEUTICAL AND HEALTHCARE PRODUCTS AND SERVICES ("PROPOSED DIVERSIFICATION") | On behalf of the Board of Directors of MGRC, TA Securities Holdings Berhad wishes to announce that the Company proposes to undertake the Proposed Diversification.
Please refer to the attachment below for further details of the Proposed Diversification.
This announcement is dated 12 October 2020. | https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3095442
|
|
|
|
|
|
|
|
楼主 |
发表于 8-3-2021 08:30 AM
|
显示全部楼层
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Particulars of substantial Securities HolderName | LIW CHAI YUK | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 14 Oct 2020 | 2,000,000 | Disposed | Direct Interest | Name of registered holder | Liw Chai Yuk | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of 2,000,000 shares via off market transaction. | Nature of interest | Direct Interest | Direct (units) | 6,061,000 | Direct (%) | 5.855 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 6,061,000 | Date of notice | 16 Oct 2020 | Date notice received by Listed Issuer | 16 Oct 2020 |
|
|
|
|
|
|
|
|
楼主 |
发表于 16-3-2021 08:52 AM
|
显示全部楼层
本帖最后由 icy97 于 30-8-2021 08:33 AM 编辑
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Particulars of substantial Securities HolderName | CREST ADVISORY BERHAD | Address | 100.3.041 129 Offices, Block J,
Jaya One, 72A, Jalan Universiti,
Section 13,
Petaling Jaya
46200 Selangor
Malaysia. | Company No. | 201901013684 (1323012-X) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 21 Oct 2020 | 2,000,000 | Disposed | Direct Interest | Name of registered holder | Crest Advisory Berhad | Address of registered holder | 100.3.041 129 Offices, Block J, Jaya One, 72A, Jalan Universiti, Section 13, 46200 Petaling Jaya, Selangor. | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of 2,000,000 shares in the open market. | Nature of interest | Direct Interest | Direct (units) | 22,000,000 | Direct (%) | 21.254 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 22,000,000 | Date of notice | 23 Oct 2020 | Date notice received by Listed Issuer | 23 Oct 2020 |
Name | CREST ADVISORY BERHAD | Address | 100.3.041 129 Offices, Block J,
Jaya One, 72A, Jalan Universiti,
Section 13,
Petaling Jaya
46200 Selangor
Malaysia. | Company No. | 201901013684 (1323012-X) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 28 Oct 2020 | 2,000,000 | Disposed | Direct Interest | Name of registered holder | Crest Advisory Berhad | Address of registered holder | 100.3.041 129 Offices, Block J, Jaya One, 72A, Jalan Universiti, Section 13, 46200 Petaling Jaya, Selangor. | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of 2,000,000 shares in the open market. | Nature of interest | Direct Interest | Direct (units) | 20,000,000 | Direct (%) | 19.322 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 20,000,000 | Date of notice | 02 Nov 2020 | Date notice received by Listed Issuer | 02 Nov 2020 |
Name | CREST ADVISORY BERHAD | Address | 100.3.041 129 Offices, Block J,
Jaya One, 72A, Jalan Universiti,
Section 13,
Petaling Jaya
46200 Selangor
Malaysia. | Company No. | 201901013684 (1323012-X) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 03 Nov 2020 | 2,000,000 | Disposed | Direct Interest | Name of registered holder | Crest Advisory Berhad | Address of registered holder | 100.3.041 129 Offices, Block J, Jaya One, 72A, Jalan Universiti, Section 13, 46200 Petaling Jaya, Selangor. | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of 2,000,000 shares in the open market. | Nature of interest | Direct Interest | Direct (units) | 18,000,000 | Direct (%) | 17.39 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 18,000,000 | Date of notice | 06 Nov 2020 | Date notice received by Listed Issuer | 06 Nov 2020 |
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD | Particulars of Substantial Securities HolderName | I CONCEPT GLOBAL GROWTH FUND | Address | 89, Nexus Way, Camana Bay,Grand Cayman,
KY1-9009, Cayman Islands
Cayman Islands. | Company No. | BS-328056 | Nationality/Country of incorporation | Cayman Islands | Descriptions (Class) | Ordinary Shares | Name of registered holder | I CONCEPT GLOBAL GROWTH FUND | Address of registered holder | 89, Nexus Way, Camana Bay,Grand Cayman, KY1-9009, Cayman Islands |
Date interest acquired & no of securities acquired | Date interest acquired | 04 Nov 2020 | No of securities | 1,200,000 | Circumstances by reason of which Securities Holder has interest | Acquisition of 1,200,000 shares in the open market. The total of shares after the acquisition is 6,200,000 shares and becoming a Substantial Shareholder of the Company. | Nature of interest | Direct Interest | | Total no of securities after change | Direct (units) | 6,200,000 | Direct (%) | 5.99 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Date of notice | 06 Nov 2020 | Date notice received by Listed Issuer | 06 Nov 2020 |
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2020 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2020 | 30 Sep 2019 | 30 Sep 2020 | 30 Sep 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 87 | 179 | 87 | 179 | 2 | Profit/(loss) before tax | -833 | -509 | -833 | -509 | 3 | Profit/(loss) for the period | -833 | -33 | -833 | -33 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -833 | -33 | -833 | -33 | 5 | Basic earnings/(loss) per share (Subunit) | -0.80 | -0.03 | -0.80 | -0.03 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0911 | 0.0991
|
Notice of Person Ceasing (Section 139 of CA 2016)MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD | Particulars of Substantial Securities HolderName | LIW CHAI YUK | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | Liw Chai Yuk | Date of cessation | 16 Dec 2020 |
No of securities disposed | 1,000,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal of 1,000,000 shares in the open market. She ceased to be a Substantial Shareholder of the Company upon the disposal. | Nature of interest | Direct Interest | | Date of notice | 18 Dec 2020 | Date notice received by Listed Issuer | 18 Dec 2020 |
Name | CREST ADVISORY BERHAD | Address | 100.3.041 129 Offices, Block J,
Jaya One, 72A, Jalan Universiti,
Section 13,
Petaling Jaya
46200 Selangor
Malaysia. | Company No. | 201901013684 (1323012-X) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 16 Dec 2020 | 2,000,000 | Disposed | Direct Interest | Name of registered holder | Crest Advisory Berhad | Address of registered holder | 100.3.041 129 Offices, Block J, Jaya One, 72A, Jalan Universiti, Section 13, 46200 Petaling Jaya, Selangor. | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of 2,000,000 shares in the open market. | Nature of interest | Direct Interest | Direct (units) | 16,250,000 | Direct (%) | 15.699 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 16,250,000 | Date of notice | 18 Dec 2020 | Date notice received by Listed Issuer | 18 Dec 2020 |
Type | Announcement | Subject | OTHERS | Description | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company")- EVALUATION OF PARTICIPATION IN THE AMERICAN DEPOSITARY RECEIPT ("ADR") PROGRAM | The Board of Directors (“Board”) of MGRC wishes to inform that the Company is evaluating a potential future participation in the American Depositary Receipt (“ADR”) Program (“Proposed ADR”) to facilitate the trading of the Company’s shares by investors in the United States of America ("the US").
The Proposed ADR is still at a preliminary stage where the Company intends to evaluate its eligibility, and the costs and benefits of participation. The structure of the Proposed ADR is not finalised. More details in relation to the Proposed ADR will be made available in due course, if and when the Board completes the evaluation, and finalises and approves the Proposed ADR.
Typically, ADRs are issued by a US depository bank to represent a foreign company’s shares, and provide an avenue for US-based investors to purchase said shares. The ADRs can provide foreign companies, such as MGRC, with access to a larger, more diversified investor base.
If the Board opts to proceed to participate in the Proposed ADR in the future, the Proposed ADR will be subject to the approvals from all the relevant authorities in Malaysia, the US, and other applicable jurisdictions, as well as approval from the shareholders of the Company.
The Board will disseminate any material information in relation to evaluation of the Proposed ADR in accordance with ACE Market Listing Requirements of Bursa Malaysia Securities Berhad.
The announcement is made on 11 January 2021. |
|
|
|
|
|
|
|
| |
本周最热论坛帖子
|